Search over 3,000 reports

    Hemophilia B - Epidemiology Forecast to 2025

    Hemophilia B - Epidemiology Forecast to 2025
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 40
    Geography: Global
    Delivery Timeline: 5 Business Days
    SKU: DIEI0103
    DelveInsight's "Hemophilia B -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Hemophilia B in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Hemophilia B. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Hemophilia B. The report contains the targeted patient populations and the forecast methodology.

    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

    Key Coverage and Benefits

    • The Report includes the prevalent population and how will it change over the next eight years.
    • Coverage of key Hemophilia B sub-populations and its prevalent or incident cases
    • Prevalent or incident cases segmented by age and sex.
    • The key differences in epidemiology patterns across the seven market segments.

    Reasons to buy
    • Developing business strategies by understanding the trends shaping and driving the global Hemophilia B market.
    • Identifying prevalent patient populations as well as risk factors in the global Hemophilia B market will help to improve product design, pricing, and launch plans.
    • Organize sales and marketing efforts by identifying the best opportunities for Hemophilia B therapeutics in each of the markets covered.

    1. Report Introduction
    2. Snapshot of Total Prevalent or Incident cases by 7 MM
    3. Executive Summary
    • Key Findings
    4. Hemophilia B Overview
    • Hemophilia B Definition
    • Pathophysiology
    • Symptoms
    • Etiology
    5. Risk Factors Associated with Hemophilia B
    6. Disease Burden & Unmet Need in the Market
    7. Epidemiology and Patient Populations
    • Key Findings
    • Key Sources used and Forecast Methodology
    • Prevalent Cases and Incident Cases-2015-2025
    • Prevalent & Incident Cases by Category-2015-2025
    • Age-Specific Prevalent/ Incident Cases of Hemophilia B
    • Sex-Specific Prevalent/Incident Cases of Hemophilia B
    • Disease Type Specific Prevalent/Incident Cases of Hemophilia B
    8.Prevalent & Incident Cases by 7 MM-2015-2025
    • Hemophilia B Epidemiology of United States-2025
    • Hemophilia B Epidemiology of United Kingdom-2025
    • Hemophilia B Epidemiology of Germany-2025
    • Hemophilia B Epidemiology of France-2025
    • Hemophilia B Epidemiology of Spain-2025
    • Hemophilia B Epidemiology of Italy-2025
    • Hemophilia B Epidemiology of Japan-2025
    9. Key Takeaways
    10. Appendix
    11.Report Methodology
    12. Consulting Services
    13. Disclaimer
    14. About Us
    Table 1: Clinical subtypes of Indication
    Table 2: Risk Factors
    Table 3: Prevalence cases (%) Region wise
    Table 4: Sources used for forecasting the data
    Table 5: Hemophilia B Global Epidemiology, (2015-2025)
    Table 6: Prevalent Cases of Hemophilia B (Ages =XX Years), US (2015-2025)
    Table 7: Prevalent Cases of Hemophilia B By Sex (Males & Females), US (2015-2025)
    Table 8: Prevalent Cases By Hemophilia B Sub-population, US (2015-2025)
    Table 9: Prevalent Cases of Hemophilia B (Ages =XX Years), United Kingdom (2015-2025)
    Table 10: Prevalent Cases of Hemophilia B By Sex (Males & Females), United Kingdom (2015-2025)
    Table 11: Prevalent Cases By Hemophilia B Sub-population, United Kingdom (2015-2025)
    Table 12: Prevalent Cases of Hemophilia B (Ages =XX Years), Germany (2015-2025)
    Table 13: Prevalent Cases of Hemophilia B By Sex (Males & Females), Germany (2015-2025)
    Table 14: Prevalent Cases By Hemophilia B Sub-population, Germany (2015-2025)
    Table 15: Prevalent Cases of Hemophilia B (Ages =XX Years), France (2015-2025)
    Table 16: Prevalent Cases of Hemophilia B By Sex (Males & Females), France (2015-2025)
    Table 17: Prevalent Cases By Hemophilia B Sub-population, France (2015-2025)
    Table 18: Prevalent Cases of Hemophilia B (Ages =XX Years), Italy (2015-2025)
    Table 19: Prevalent Cases of Hemophilia B By Sex (Males & Females), Italy (2015-2025)
    Table 20: Prevalent Cases By Hemophilia B Sub-population, Italy (2015-2025)
    Table 21: Prevalent Cases of Hemophilia B (Ages =XX Years), Spain (2015-2025)
    Table 22: Prevalent Cases of Hemophilia B By Sex (Males & Females), Spain (2015-2025)
    Table 23: Prevalent Cases By Hemophilia B Sub-population, Spain (2015-2025)
    Table 24: Prevalent Cases of Hemophilia B (Ages =XX Years), Japan (2015-2025)
    Table 25: Prevalent Cases of Hemophilia B By Sex (Males & Females), Japan (2015-2025)
    Table 26: Prevalent Cases By Hemophilia B Sub-population, Japan (2015-2025)
    Figure 1: Prevalence cases (%) Region wise
    Figure 2: Sources used for forecasting the data
    Figure 3: Hemophilia B Global Epidemiology, (2015-2025)
    Figure 4: Prevalent Cases of Hemophilia B (Ages =XX Years), US (2015-2025)
    Figure 5: Prevalent Cases of Hemophilia B By Sex (Males & Females), US (2015-2025)
    Figure 6: Prevalent Cases By Hemophilia B Sub-population,US (2015-2025)
    Figure 7: Prevalent Cases of Hemophilia B (Ages =XX Years), United Kingdom (2015-2025)
    Figure 8: Prevalent Cases of Hemophilia B By Sex (Males & Females), United Kingdom (2015-2025)
    Figure 9: Prevalent Cases By Hemophilia B Sub-population,United Kingdom (2015-2025)
    Figure 10: Prevalent Cases of Hemophilia B (Ages =XX Years), Germany (2015-2025)
    Figure 11: Prevalent Cases of Hemophilia B By Sex (Males & Females), Germany (2015-2025)
    Figure 12: Prevalent Cases By Hemophilia B Sub-population,Germany (2015-2025)
    Figure 13: Prevalent Cases of Hemophilia B (Ages =XX Years), France (2015-2025)
    Figure 14: Prevalent Cases of Hemophilia B By Sex (Males & Females), France (2015-2025)
    Figure 15: Prevalent Cases By Hemophilia B Sub-population,France (2015-2025)
    Figure 16: Prevalent Cases of Hemophilia B (Ages =XX Years), Italy (2015-2025)
    Figure 17: Prevalent Cases of Hemophilia B By Sex (Males & Females), Italy (2015-2025)
    Figure 18: Prevalent Cases By Hemophilia B Sub-population,Italy (2015-2025)
    Figure 19: Prevalent Cases of Hemophilia B (Ages =XX Years), Spain (2015-2025)
    Figure 20: Prevalent Cases of Hemophilia B By Sex (Males & Females), Spain (2015-2025)
    Figure 21: Prevalent Cases By Hemophilia B Sub-population,Spain (2015-2025)
    Figure 22: Prevalent Cases of Hemophilia B (Ages =XX Years), Japan (2015-2025)
    Figure 23: Prevalent Cases of Hemophilia B By Sex (Males & Females), Japan (2015-2025)
    Figure 24: Prevalent Cases By Hemophilia B Sub-population,Japan (2015-2025)
    Hemophilia B Disease Overview

    Hemophilia B Prevalence

    Hemophilia B Incidence

    Hemophilia B Risk Factors

    Hemophilia B Epidemiology

    Hemophilia B Patient Populations

    Hemophilia B Diagnosed Patients

    Hemophilia B Forecast

    Hemophilia B Epidemiology Forecast

    Hemophilia B Treated patients/population

    • Single User License
      (20% Off)
      $2,950.00
    • Site License
      (30% Off)
      $5,900.00
    • Global License
      (40% Off)
      $8,850.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap